PHARMACY

Panelists discussed health and wellness innovation, the Nourish My Health public education campaign and pharmacy’s role in value-based care, among other topics.

Several essential reforms have advanced in the 118th Congress, such as Medicaid managed care pharmacy payment reform and a ban on spread pricing.

Attendees will have the opportunity to hear from former FDA Commissioner Dr. Scott Gottlieb and others.

The intended divestiture is expected to play an important role in Teva's “Pivot to Growth” strategy.

The 2024 Conference—“Within Reach”—takes place Feb. 11 to 13 in Bonita Springs, Fla., and is the kick-off to NACDS meetings and conferences this year.

Ryan will speak at the Chain Members and Political Action Committee Breakfast.

Lupin obtained approval for generic BromSite and generic Multaq and launched generic Nascobal.

Empower Pharma is expected to use the facility to expand its 503A, 503B and contract development and manufacturing organization operations for the pharmaceutical industry.